Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

近日，广东天承科技股份有限公司（以下简称"公司"或"天承科技"）全 资子公司广东天承化学有限公司（以下简称"天承化学"）收到珠海市自然资源 局出具的《征缴土地闲置费决定书》（珠自然资金闲置征决[2025]002 号）（以下 简称"《决定书》"），现将有关情况公告如下： 一、《决定书》主要内容及公司缴费情况 证券代码：688603 证券简称：天承科技 公告编号：2025-027 广东天承科技股份有限公司 关于全资子公司收到《征缴土地闲置费决定书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《珠海市闲置土地处置实施细则》第二十二条第（一）项、第二十四 条的规定，珠海市自然资源局决定对天承化学名下一宗闲置土地按照国有建设 用地使用权人实际应缴土地价款本金（不包含滞纳金及利息）总额的百分之二 十征缴土地闲置费，土地闲置费数额为 216.5782 万元。自决定书送达之日起 30 日内到税务部门办理土地闲置费缴纳手续。 该闲置土地为工业用地，土地证号：粤（2022）珠海市不动产第 0401061 号，位于珠海经济技术开 ...

Summary of Key Points Core Viewpoint - The announcement details a share reduction plan by a significant shareholder, Rui Xing Phase II, due to personal funding needs, which may impact the company's stock performance and investor sentiment [1][4]. Shareholder Information - Rui Xing Phase II directly holds 2,533,542 shares, representing 3.0177% of the total share capital of the company [1]. - The shareholder is not a controlling shareholder or a major stakeholder [1]. Reduction Plan Details - The reduction plan is set to occur from May 23, 2025, to August 20, 2025, with a maximum reduction of 2,518,714 shares, not exceeding 3% of the total share capital [2][3]. - The reduction will be executed through centralized bidding and block trading, with up to 839,571 shares through centralized bidding and 1,679,143 shares through block trading [2]. Reason for Reduction - The primary reason for the share reduction is the shareholder's personal funding needs [4]. Compliance and Commitments - Rui Xing Phase II has made commitments regarding the reduction, including prior announcements three trading days before any share reduction and adherence to relevant regulations [4][5]. - The company confirms that the reduction plan aligns with previously disclosed commitments and will not lead to a change in control [5].

证券代码：688603 证券简称：天承科技 公告编号：2025-026 广东天承科技股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东的基本情况 截至本公告披露日，宁波市睿兴二期股权投资合伙企业（有限合伙）（以下 简称"睿兴二期"）直接持有公司股份 2,533,542 股，占总股本的 3.0177%。 减持计划的主要内容 公司于 2025 年 5 月 16 日收到股东睿兴二期发来的《关于股东减持计划的告 知函》,因股东自身资金需求，睿兴二期计划自 2025 年 5 月 23 日至 2025 年 8 月 20 日期间，通过大宗交易和集中竞价的方式合计减持公司股份不超过 2,518,714 股，合计减持股份占公司总股本的比例不超过 3%。 | 股东名称 | 睿兴二期 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 | √否 | | | 直接持股 5%以上股东 | □是 | √否 | | | ...

Core Viewpoint - Tiancheng Technology (688603.SH) has faced delays in its fundraising projects, with significant implications for its operational strategy and future growth [1][2]. Group 1: Financial Performance and Fundraising - Tiancheng Technology disclosed a total investment of 112.61 million yuan in fundraising by the end of 2024, with a cumulative investment progress of 15.92% [1]. - The company raised a total of 799.38 million yuan through its IPO, with a net amount of 707.38 million yuan after deducting issuance costs, which was 306.29 million yuan more than originally planned [2]. - The IPO was conducted at a price of 55.00 yuan per share, with 14.53 million shares issued, representing 25% of the total share capital post-issuance [2]. Group 2: Project Development and Delays - The "Annual Production of 30,000 Tons of Special Electronic Materials and Electronic Chemicals Project" and the "Zhuhai R&D Center Construction Project" both have a progress rate of 0%, with completion dates postponed to April 2027 [1]. - The slow progress of the projects is attributed to the company's strategy of unified project planning and design, which requires land acquisition for the Zhuhai R&D Center, which has been delayed due to policy changes [1]. - The company aims to improve the efficiency of fundraising usage and avoid resource duplication, leading to the decision to synchronize the development of related projects [1]. Group 3: Strategic Partnerships - Minsheng Securities Investment Co., a subsidiary of the lead underwriter, participated in a strategic allocation, acquiring 726,711 shares, which is 5% of the total issuance, with an investment amount of approximately 39.97 million yuan [3]. - The shares acquired by Minsheng Investment are subject to a holding period of 24 months from the date of the IPO [3].

Dividend and Share Capital - The company plans to distribute a cash dividend of 3 CNY per 10 shares, totaling 24,959,591 CNY, which represents 84.00% of the net profit attributable to shareholders for the year [6]. - The company intends to increase its capital reserve by issuing 4.9 new shares for every 10 shares held, resulting in a total of 40,767,332 new shares, increasing total shares to 124,724,524 [7]. - The total amount of cash dividends and share repurchases combined is 62,732,713.82 RMB, which represents 84.00% of the net profit attributable to shareholders for the year [196]. - The cash dividend amount accounts for 33.42% of the net profit attributable to shareholders, which is 74,679,913.48 RMB [200]. Financial Performance - The company reported a revenue increase of 15% year-over-year, reaching $1.2 billion in Q3 2023 [15]. - The company's revenue for 2024 reached ¥380,670,972.91, representing a 12.32% increase compared to ¥338,928,877.29 in 2023 [27]. - The net profit attributable to shareholders for 2024 is CNY 74,679,913.48, an increase of 27.50% compared to the same period last year [28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is CNY 62,111,324.27, up 13.16% year-on-year [28]. - The net cash flow from operating activities for 2024 is CNY 71,096,999.52, reflecting a 14.37% increase from the previous year [30]. - The company's operating revenue for the current period is CNY 380,670,972.91, representing a 12.32% increase compared to CNY 338,928,877.29 in the same period last year [106]. - Operating costs increased by 5.07% to CNY 228,957,065.57 from CNY 217,915,269.81 year-on-year [106]. - The gross profit margin for the main business increased by 4.17 percentage points to 39.76% [110]. Research and Development - The company is investing $200 million in R&D for advanced packaging technologies, aiming to enhance product performance [15]. - The R&D expenditure as a percentage of operating revenue is 7.35%, an increase of 0.75 percentage points from 6.60% in 2023 [29]. - The total R&D investment for the year was approximately ¥27,968,219, an increase of 25.03% compared to the previous year [85]. - The company has increased its R&D personnel from 48 to 58, representing 25.66% of the total workforce [93]. - The company is focusing on developing high-end products to break the monopoly of foreign companies and fill domestic technology gaps [76]. - The company has established multiple core technologies related to PCB, chip packaging materials, and touch screens, maintaining strong core competitiveness [77]. Market Expansion and Strategy - The company plans to enter the European market by Q2 2024, targeting a revenue contribution of $100 million in the first year [15]. - Market expansion efforts have led to a 20% increase in market share in the Asia-Pacific region [16]. - The company is focusing on the development of functional wet electronic chemicals for semiconductor and photovoltaic applications [160]. - The company aims to enhance its market share in high-end printed circuit board products, particularly in copper plating and electroplating applications [160]. - The company is actively exploring new strategies to improve operational efficiency and reduce costs [17]. Corporate Governance - The company has received a standard unqualified audit report from Beijing Dehao International Accounting Firm [5]. - The company has confirmed that all board members attended the board meeting, ensuring governance compliance [5]. - The company has not reported any violations of decision-making procedures regarding external guarantees [10]. - The company has not indicated any special arrangements in corporate governance [8]. - The management emphasized the importance of maintaining high-quality standards in production processes to meet customer demands [17]. Risks and Challenges - The company has outlined potential risks in its management discussion and analysis section, advising investors to be cautious [4]. - The company faces risks from intensified market competition and fluctuations in raw material prices, which could adversely affect its operating performance [101]. - The company recognizes the risk of foreign competitors dominating the high-end market due to their brand, capital, and technological advantages [102]. Employee and Management Structure - The company has a total of 226 employees, with 32 in the parent company and 194 in major subsidiaries [190]. - The employee composition includes 38 production personnel, 17 sales personnel, 67 technical personnel, 11 financial personnel, 35 administrative personnel, and 58 research and development personnel [190]. - The company established a competitive and performance-oriented compensation system, linking personal income to performance and contributions [192]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to RMB 5.9527 million [177]. Product Development and Innovation - The company has developed advanced semiconductor electroplating copper products with excellent filling capabilities and fine line capabilities [80]. - The company has made significant advancements in micro-etching technology, improving the stability of the etching rate and reducing overall production costs [80]. - The company is actively expanding its product offerings in semiconductor advanced packaging, focusing on key technologies and materials to support the growing demand for high-performance computing [58]. - The company has developed silicon via TSV electroplating additives that meet international standards, focusing on providing advanced solutions for leading customers [61]. Financial Management - The company has improved cash management strategies, leading to enhanced efficiency in fund utilization [28]. - The company experienced a substantial reduction in net cash flow from financing activities, decreasing by 109.85% to CNY -69,771,627.01 from CNY 708,314,039.20 in the previous year [107]. - The company's cash and cash equivalents decreased by 26.60% to ¥176,566,909.98 from ¥240,551,420.33 due to increased investments in financial products [126].

Core Viewpoint - Tiancheng Technology has reported that the progress of its two IPO fundraising projects, namely the "Annual Production of 30,000 Tons of Special Electronic Materials Chemical Products Project" and the "Zhuhai R&D Center Construction Project," is currently at 0% due to the lack of land use rights for the Zhuhai project [1][5]. Group 1: Project Progress - As of the end of last year, both the "Annual Production of 30,000 Tons of Special Electronic Materials Chemical Products Project" and the "Zhuhai R&D Center Construction Project" have not commenced construction [2][5]. - The company stated that the slow progress of the Zhuhai R&D Center is primarily due to policy adjustments that have delayed the acquisition of necessary land use rights [5]. Group 2: Financial Performance - Since its listing in July 2023, the company has experienced continuous growth in sales revenue and profits, indicating that the development of its main business does not currently rely on the implementation of the fundraising projects [5]. Group 3: Inventory Management - As of the end of 2024, the company's issued goods account balance is approximately 25.88 million yuan, accounting for 64.83% of the total inventory balance [6]. - The company explained that the issued goods are primarily products sent to customers based on their expected consumption, which have not yet met the revenue recognition criteria due to not being signed for by the customers [9].

民生证券股份有限公司关于广东天承科技股份有限公司 2024年报告的信息披露监管问询函的核查意见 上海证券交易所： 根据贵所出具的《关于广东天承科技股份有限公司 2024 年报告的信息披露 监管问询函》 （上证科创公函【2025】0062 号）（以下简称"年报问询函" ） 的要求，民生证券股份有限公司（以下简称"持续督导机构"）作为广东天承科 技股份有限公司（以下简称"天承科技"或"公司"）首次公开发行股票并在科 创板上市的保荐机构，会同公司及相关中介机构，就年报问询函提及的事项逐项 进行了认真讨论、核查与落实，并出具了核查意见如下： 一、关于营业收入。年报显示，公司营业总收入38,067.1万元，同比上升 12.32%。公司产品包括化学沉铜专用化学品、电镀专用化学品、铜面处理专用化 学品、半导体先进封装专用化学品等。公司和客户的销售结算方式主要包括包线 销售和单价销售。包线销售模式下，公司按月与客户核对结算面积或消耗电量和 结算金额，并依据客户的对账单确认销售收入。请公司：（1）分产品列示营业 收入、较上年增减变动情况及原因；（2）列示不同销售结算方式下营业收入、 销售数量、价格、毛利率情况，分析营业收入变动 ...

证券代码：688603 证券简称：天承科技 公告编号：2025-025 广东天承科技股份有限公司关于 2024 年报告的信息披露监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广东天承科技股份有限公司（以下简称"公司"或"天承科技"）于近日收 到上海证券交易所下发的《关于广东天承科技股份有限公司 2024 年报告的信息 披露监管问询函》（上证科创公函【2025】0062 号），以下简称"年报问询函"）。 根据年报问询函的要求，公司与民生证券股份有限公司（以下简称"持续督导 机构"）、北京德皓国际会计师事务所（特殊普通合伙）（以下简称"年审会计 师"）对年报问询函所提及的事项进行了认真核查并作出回复。现就有关问题回 复如下： 回复中楷体加粗部分为公司《2024 年年度报告》补充披露或修改部分。本 回复报告中若合计数与各分项数值相加之和在尾数上存在差异均为四舍五入所 致。鉴于公司回复内容中披露的部分信息涉及商业秘密，因此公司针对该部分 内容进行豁免披露。 1、关于营业收入。年报显示，公司营业总收入 38, ...

关于对广东天承科技股份有限公司 2024年 年报问询函中有关财务事项的说明 德皓函字[2025]00000046 号 上海证券交易所: 由广东天承科技股份有限公司(以下简称天承科技公司或公 司) 转来的《关于广东天承科技股份有限公司 2024年报告的信息披 露监管问询函》(上证科创公函【2025】0062 号,以下简称问询 函)奉悉。我们已对审核问询函所提及的财务事项进行了审慎核 查,现汇报如下: 本问询函复中,除特殊说明外,金额单位均为万元,若合计 数与各分项数值相加之和在尾数上存在差异,均为四舍五入所致。 问询问题一:关于营业收入 年报显示,公司营业总收入 38,067.1 万元,同比上升 12.32%。公司产品包 括化学沉铜专用化学品、电镀专用化学品、铜面处理专用化学品、半导体先进 封装专用化学品等。公司和客户的销售结算方式主要包括包线销售和单价销 售。包线销售模式下,公司按月与客户核对结算面积或消耗电量和结算金额, 并依据客户的对账单确认销售收入。请公司:(1)分产品列示营业收入、较上 年增减变动情况及原因; (2)列示不同销售结算方式下营业收入、销售数量、 价格、毛利率情况,分析营业收入变动的原因; ...